<DOC>
	<DOC>NCT02492464</DOC>
	<brief_summary>This will be a double-blind randomized clinical trial carried out on subjects with suboptimal control of LDL-cholesterolemia, following a Mediterranean diet, and treated with a red yeast rice extract (containing 10 mg monacolin K per daily dose) or placebo, in order to evaluate the middle-term effects on vascular health evaluated by non invasive methods (Vicorder(R) apparatus)</brief_summary>
	<brief_title>Effects of 10 mg Monacolins on Vascular Health: a Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Red yeast rice</mesh_term>
	<criteria>LDLcholesterol between 130 and 190 mg/dL Secundary prevention for cardiovascular disease Type 2 diabetes Assumption of lipidlowering drug or dietary supplements Previous intolerans to read yeast rice including dietary supplements</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>